p53 Is Active in Human Amniotic Fluid Stem Cells
Author(s) -
Melissa Rodrigues,
Ivana Antonucci,
Seham Elabd,
Shilpa Kancherla,
Marco Marchisio,
Christine Blattner,
Liborio Stuppia
Publication year - 2018
Publication title -
stem cells and development
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 114
eISSN - 1557-8534
pISSN - 1547-3287
DOI - 10.1089/scd.2017.0254
Subject(s) - biology , amniotic fluid , amniotic epithelial cells , stem cell , microbiology and biotechnology , amniotic stem cells , cell , lineage (genetic) , cellular differentiation , gene , adult stem cell , fetus , genetics , pregnancy
Despite increasing interest in human amniotic fluid cells, very little is known about the regulation and function of p53 in this cell type. In this study, we show that undifferentiated human amniotic fluid cells express p53, yet at lower levels than in cancer cells. The p53 protein in amniotic fluid cells is mainly localized in the nuclei, however, its antiproliferative activity is compromised in these cells. Igf2, a maternal imprinted gene, and c-jun, a proto-oncogene, are regulated by p53 in these cells. DNA damage leads to an increase in p53 abundance in human amniotic fluid cells and to transcriptional activation of its target genes. Interestingly, cell differentiation toward the neural lineage leads to p53 induction as differentiation progresses.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom